{
    "organizations": [],
    "uuid": "4e6401501f432c8364da23c38c5d545f7ba1b67c",
    "author": "",
    "url": "https://www.reuters.com/article/brief-scythian-biosciences-announces-ext/brief-scythian-biosciences-announces-extension-of-letter-of-intent-idUSFWN1RB0ZI",
    "ord_in_thread": 0,
    "title": "BRIEF-Scythian Biosciences Announces Extension of Letter of Intent",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 29 (Reuters) - Scythian Biosciences Corp:\n* SIGNED AN AGREEMENT TO EXTEND ITS PREVIOUSLY ANNOUNCED LETTER OF INTENT TO ACQUIRE MMJ INTERNATIONAL INVESTMENTS\n* SCYTHIAN BIOSCIENCES -AGREEMENT EXTENDS DEADLINE FOR NEGOTIATING, ENTERING INTO DEFINITIVE AGREEMENT WITH MMJ FROM MARCH 31, 2018 TO APRIL 30, 2018\n* SCYTHIAN HAS ANNOUNCED THE DEPARTURE OF DAVID SCHRADER AS CHIEF OPERATING OFFICER EFFECTIVE MARCH 31, 2018 Source text for Eikon: Further company coverage:\n ",
    "published": "2018-03-30T02:00:00.000+03:00",
    "crawled": "2018-03-30T02:14:44.000+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "reuters",
        "scythian",
        "bioscience",
        "corp",
        "signed",
        "agreement",
        "extend",
        "previously",
        "announced",
        "letter",
        "intent",
        "acquire",
        "mmj",
        "international",
        "investment",
        "scythian",
        "bioscience",
        "extends",
        "deadline",
        "negotiating",
        "entering",
        "definitive",
        "agreement",
        "mmj",
        "march",
        "april",
        "scythian",
        "announced",
        "departure",
        "david",
        "schrader",
        "chief",
        "operating",
        "officer",
        "effective",
        "march",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}